Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

S&P 500 Futures - Jun 24

CME
Symbol
Exchange
Currency
ESM24CMEUSD
US500DerivedUSD
ESc2CMEUSD
ESc3CMEUSD
Currency in USD
Disclaimer
5,125.50
+18.00(+0.35%)
Delayed Data

S&P 500 Futures Discussions

There is someone that thinks outside the box.... the director of the Oxford Vaccine Group says existing vaccines should work against the new strain, but that would only become apparent after more research.
He's not alone, reality is they don't know anything yet "What you need to do, is you need to get that particular sequence of the virus, put it in a form in the lab where you can actually test the different antibodies, so you can have a prediction that it might evade, or you can actually prove it," he said."Right now, you're talking about sort of like a red flag that this might be an issue, but we don't know," Fauci added. "Once you test it, you'll know for sure whether or not it does or does not evade the antibodies that we make, for example, against the virus through a vaccine or ... after you get infected."Dr. Ashish Jha, dean of the Brown University School of Public Health, said he does not believe the variant will create a situation where "vaccines will be rendered useless.""I think that's exceedingly unlikely," he said. "The question is, is there a tiny hit to vaccine efficacy, or is there a large hit? I think we'll get some preliminary data probably in the next few days."
Sir Andrew Pollard went further stating that If you look at where most of the mutations are, they are similar to regions of the spike protein that have been seen with other variants so far.... he told BBC Radio 4’s Today programme.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.